For comparison, a major clinical trial published in the New England Journal of Medicine found adults taking semaglutide -- the active ingredient in Wegovy -- lost an average of 14.9% of their body weight over 68 weeks
Recent advances in the identification of crystallized structure, the spectrum of binding sites, and the mechanism of biased agonism are now facilitating the discovery of small molecule GLP-1 receptor agonists, all of which have a molecular weight of less than 1,000 g/mol
For GLP-1, the review confirmed insulinotropic effects on -cells during hyperglycaemia, glucagonostatic effects on -cells during hyperglycaemia (indirect, via somatostatin and insulin), gastric emptying delay, CNS appetite suppression, and indirect promotion of lipolysis via increased sympathetic activity
I was a snacker, but not anymore
They found widespread associations with benefits to cognitive and behavioral health, while also revealing increased risks for pancreatitis and kidney conditions, among others
Participants who made it past week 12 without discontinuing had an 87% chance of achieving at least 15% weight loss by week 48
